Who They Are
This audience skews female (though not exclusively), roughly 25–50 years old, and is health-curious rather than medically desperate — many are not clinically obese but want to lose 10–30 lbs for a specific event, aesthetic goal, or quality-of-life reason. They've tried conventional approaches (dieting, exercise, calorie counting) and feel stuck or exhausted by the effort-to-result ratio. They're digitally fluent, influenced by peer conversations and social proof, and are actively researching GLP-1 medications — aware they exist but uncertain whether they "qualify" or whether the trade-offs are worth it. Many feel gatekept by traditional healthcare (BMI requirements, insurance barriers, waitlists) and are drawn to telehealth and DTC models that remove friction. They think of weight management as tied to confidence and life participation, not just health metrics.
Pains & Desires
Pains
- BMI Gatekeeping: Being told they don't qualify for GLP-1s because they aren't heavy "enough" is a top frustration — many feel dismissed by conventional systems despite genuine struggles.
- Constant Food Noise: The mental exhaustion of thinking about food, cravings, and what to eat next is described as relentless and demoralizing — more tiring than the physical weight itself.
- Effort Without Results: Years of dieting, gym routines, and calorie restriction with inconsistent or unsustainable outcomes creates deep skepticism and fatigue.
- Needle Aversion: A significant barrier — many are interested in GLP-1s but fear or dislike injections, which blocks entry entirely.
- Cost and Insurance Opacity: High prices for branded medications and confusing coverage create real access anxiety, especially for those paying out of pocket.
- Rebound Weight Gain: Previous experience losing weight and regaining it undermines confidence in any new solution — they fear investing again only to fail again.
- Nutritional Confusion on GLP-1s: Once started, users don't know how to eat correctly — what, how much, and how to maintain muscle while appetite is suppressed.
- Side Effects and Social Stigma: Concerns about GI side effects, judgment from others about using medication to lose weight, and uncertainty about long-term use are persistent friction points.
Desires
- Quiet Around Food: The primary emotional desire is relief from preoccupation with eating — not just weight loss, but mental freedom.
- Accessible, Judgment-Free Care: They want a provider that meets them where they are without making them justify their body or weight goal.
- Visible, Believable Results: Tangible proof — fitting into a specific outfit, a before/after story from someone like them — drives conviction more than clinical claims.
- Convenience Without Compromise: Solutions that slot into busy lives (meal delivery, telehealth, dissolving tablets) feel more achievable than overhauling everything at once.
- Feeling Like Themselves Again: Confidence, energy, and a sense of being in control of their body — not a dramatic transformation, but a return to baseline.
Hook Psychology
Pain Agitation is the dominant trigger — ads that open by naming a specific frustration (being told no, thinking about food constantly, years of failed diets) consistently outperform educational openers. Identity Call-Out is the second strongest, often used to qualify viewers by size, situation, or mindset ("if you've been told your BMI is too low," "if you're any size"). Curiosity Gap performs well in article-style formats that tease expert rankings without revealing them. Social Proof via peer testimonials — especially UGC from relatable, non-celebrity women — appears in the highest-spend creatives.
Most frequent hook tactics: direct-to-camera confession, relatable scenario setup (event approaching, clothes not fitting), fake text conversation reveal, before/after progression narrative, "did you know" challenge to a common assumption, and listicle/comparison formats (product A vs. product B).
Communication Style That Resonates
Casual and conversational wins decisively over clinical — the highest-spend creatives read like a friend texting, not a doctor advising. Vulnerability is used strategically: creators share a struggle briefly before pivoting to the solution, keeping the tone empowering rather than wallowing. Humor appears occasionally (cake-with-a-message formats, playful comparison graphics) and works when it defuses stigma around GLP-1 use. Authority is borrowed, not owned — featuring a doctor or dietitian in a conversational setting (couch, not lab) adds credibility without alienating. Language is direct and outcome-specific: specific pounds, specific timeframes, specific events.
Objections & Skepticism
- "This is only for seriously obese people" — Overcome by leading with explicit inclusivity messaging and featuring talent who visually represent moderate weight goals.
- "I'll have to inject myself" — Neutralized by foregrounding tablet/sublingual formats and normalizing those who chose non-injectable options.
- "It's too expensive" — Addressed with price transparency, specific dollar amounts, discount codes, and comparisons to branded alternatives.
- "I'll just gain it back" — Countered with language about sustainable habits, complement products (meal delivery, dietitians), and long-term support framing.
- "I'm not sure it's safe for someone like me" — Doctor-in-conversation formats and "works for mild-to-moderate loss too" messaging reduce perceived risk without requiring full clinical detail.
Awareness Stage Landscape
The bulk of ad spend clusters in the Solution-Aware to Product-Aware range — audiences already know GLP-1 medications exist and are weighing options, providers, and formats. The highest-spend creatives focus on removing access barriers (BMI, needles, cost) and differentiating specific delivery mechanisms rather than explaining what GLP-1s are. There's a meaningful secondary cluster at Problem-Aware, particularly for supplement alternatives and meal support products targeting people experiencing side effects or nutritional gaps after starting medication. The largest gap — and opportunity — sits at Most-Aware: retention, long-term adherence, and "what now" content for users already on GLP-1s who need ongoing support (nutrition, fitness, community) is underdeveloped relative to acquisition-focused creative.